98 related articles for article (PubMed ID: 8906866)
1. Cell surface receptor directed targeting of toxin to human malaria parasite, Plasmodium falciparum.
Surolia N; Misquith S
FEBS Lett; 1996 Oct; 396(1):57-61. PubMed ID: 8906866
[TBL] [Abstract][Full Text] [Related]
2. Receptor-mediated targeting of toxins to intraerythrocytic parasite Plasmodium falciparum. surolia@jncasr.ac.in.
Surolia N
Adv Drug Deliv Rev; 2000 Mar; 41(2):163-70. PubMed ID: 10699312
[TBL] [Abstract][Full Text] [Related]
3. An immunotoxin composed of a monoclonal antitransferrin receptor antibody linked by a disulfide bond to the ribosome-inactivating protein gelonin: potent in vitro and in vivo effects against human tumors.
Scott CF; Goldmacher VS; Lambert JM; Jackson JV; McIntyre GD
J Natl Cancer Inst; 1987 Nov; 79(5):1163-72. PubMed ID: 3500356
[TBL] [Abstract][Full Text] [Related]
4. Toxin-targeted design for anticancer therapy. II: Preparation and biological comparison of different chemically linked gelonin-antibody conjugates.
Delprino L; Giacomotti M; Dosio F; Brusa P; Ceruti M; Grosa G; Cattel L
J Pharm Sci; 1993 Jul; 82(7):699-704. PubMed ID: 8360843
[TBL] [Abstract][Full Text] [Related]
5. A chimeric saporin-transferrin conjugate compared to ricin toxin: role of the carrier in intracellular transport and toxicity.
Ippoliti R; Lendaro E; D'Agostino I; Fiani ML; Guidarini D; Vestri S; Benedetti PA; Brunori M
FASEB J; 1995 Sep; 9(12):1220-5. PubMed ID: 7672515
[TBL] [Abstract][Full Text] [Related]
6. Targeting cancer cells with transferrin conjugates containing the non-toxic type 2 ribosome-inactivating proteins nigrin b or ebulin l.
Citores L; Ferreras JM; Muñoz R; Benítez J; Jiménez P; Girbés T
Cancer Lett; 2002 Oct; 184(1):29-35. PubMed ID: 12104045
[TBL] [Abstract][Full Text] [Related]
7. Polynucleotide: adenosine glycosidase activity of immunotoxins containing ribosome-inactivating proteins.
Barbieri L; Bolognesi A; Valbonesi P; Polito L; Olivieri F; Stirpe F
J Drug Target; 2000; 8(5):281-8. PubMed ID: 11328656
[TBL] [Abstract][Full Text] [Related]
8. Quantitative analysis of protein synthesis inhibition and recovery in CRM107 immunotoxin-treated HeLa cells.
Wenning LA; Yazdi PT; Murphy RM
Biotechnol Bioeng; 1998 Feb; 57(4):484-96. PubMed ID: 10099226
[TBL] [Abstract][Full Text] [Related]
9. Photoactivation of toxin conjugates.
Goldmacher VS; Senter PD; Lambert JM; Blättler WA
Bioconjug Chem; 1992; 3(2):104-7. PubMed ID: 1515463
[TBL] [Abstract][Full Text] [Related]
10. An additional mechanism of ribosome-inactivating protein cytotoxicity: degradation of extrachromosomal DNA.
Nicolas E; Goodyer ID; Taraschi TF
Biochem J; 1997 Oct; 327 ( Pt 2)(Pt 2):413-7. PubMed ID: 9359409
[TBL] [Abstract][Full Text] [Related]
11. Characterization of the defect in a variant of HL-60 promyelocytic leukemia cells with reduced transferrin receptor expression.
Ishiguro K; Ho PT; Sartorelli AC
Somat Cell Mol Genet; 1992 Jan; 18(1):45-63. PubMed ID: 1546369
[TBL] [Abstract][Full Text] [Related]
12. Design, expression, purification, and characterization, in vitro and in vivo, of an antimelanoma single-chain Fv antibody fused to the toxin gelonin.
Rosenblum MG; Cheung LH; Liu Y; Marks JW
Cancer Res; 2003 Jul; 63(14):3995-4002. PubMed ID: 12873997
[TBL] [Abstract][Full Text] [Related]
13. Influence of cellular trafficking on protein synthesis inhibition of immunotoxins directed against the transferrin receptor.
Yazdi PT; Wenning LA; Murphy RM
Cancer Res; 1995 Sep; 55(17):3763-71. PubMed ID: 7641191
[TBL] [Abstract][Full Text] [Related]
14. A specific and potent immunotoxin composed of antibody ZME-018 and the plant toxin gelonin.
Rosenblum MG; Murray JL; Cheung L; Rifkin R; Salmon S; Bartholomew R
Mol Biother; 1991 Mar; 3(1):6-13. PubMed ID: 1906286
[TBL] [Abstract][Full Text] [Related]
15. Quantitative analysis of protein synthesis inhibition by transferrin-toxin conjugates.
Yazdi PT; Murphy RM
Cancer Res; 1994 Dec; 54(24):6387-94. PubMed ID: 7987833
[TBL] [Abstract][Full Text] [Related]
16. (-)-Epigallocatechin-3-Gallate Inhibits the Chaperone Activity of Plasmodium falciparum Hsp70 Chaperones and Abrogates Their Association with Functional Partners.
Zininga T; Ramatsui L; Makhado PB; Makumire S; Achilinou I; Hoppe H; Dirr H; Shonhai A
Molecules; 2017 Dec; 22(12):. PubMed ID: 29206141
[TBL] [Abstract][Full Text] [Related]
17. A new approach in the synthesis of immunotoxins: ribosome inactivating protein noncovalently bound to monoclonal antibody.
Dosio F; Brusa P; Delprino L; Grosa G; Ceruti M; Cattel L
J Pharm Sci; 1994 Feb; 83(2):206-11. PubMed ID: 8169790
[TBL] [Abstract][Full Text] [Related]
18. Characterization of translational inhibitors from Phytolacca americana. Amino-terminal sequence determination and antibody-inhibitor conjugates.
Bjorn MJ; Larrick J; Piatak M; Wilson KJ
Biochim Biophys Acta; 1984 Oct; 790(2):154-63. PubMed ID: 6091760
[TBL] [Abstract][Full Text] [Related]
19. The antibiotic micrococcin is a potent inhibitor of growth and protein synthesis in the malaria parasite.
Rogers MJ; Cundliffe E; McCutchan TF
Antimicrob Agents Chemother; 1998 Mar; 42(3):715-6. PubMed ID: 9517961
[TBL] [Abstract][Full Text] [Related]
20. In vitro selection of aptamers that bind to ribosome-inactivating toxins.
Hirao I; Yoshinari S; Yokoyama S; Endo Y; Ellington AD
Nucleic Acids Symp Ser; 1997; (37):283-4. PubMed ID: 9586110
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
